MIRA Pharmaceuticals Announces Positive Discovery of Ketamir-2’s Selective NMDA Binding Mechanism of Action
<p><i><strong>Latest positive preclinical data provides another step in the path to potential IND submission this year for novel ketamine analog</strong></i></p> MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA"...